Mesoblast (MEOBF) Payables (2017 - 2025)
Mesoblast (MEOBF) has disclosed Payables for 9 consecutive years, with $19.1 million as the latest value for Q2 2025.
- Quarterly Payables rose 169.9% to $19.1 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $19.1 million through Jun 2025, up 169.9% year-over-year, with the annual reading at $19.1 million for FY2025, 169.9% up from the prior year.
- Payables hit $19.1 million in Q2 2025 for Mesoblast, up from $7.1 million in the prior quarter.
- In the past five years, Payables ranged from a high of $23.1 million in Q2 2022 to a low of $7.1 million in Q2 2024.
- Historically, Payables has averaged $17.8 million across 5 years, with a median of $19.6 million in 2021.
- Biggest five-year swings in Payables: tumbled 64.9% in 2024 and later skyrocketed 169.9% in 2025.
- Year by year, Payables stood at $19.6 million in 2021, then rose by 17.76% to $23.1 million in 2022, then decreased by 12.71% to $20.1 million in 2023, then crashed by 64.9% to $7.1 million in 2024, then surged by 169.9% to $19.1 million in 2025.
- Business Quant data shows Payables for MEOBF at $19.1 million in Q2 2025, $7.1 million in Q2 2024, and $20.1 million in Q2 2023.